Earnings Feed
Start Free
Home/Insiders/PERRY MATTHEW D
PM
SEC Insider//CIK 0001454337

PERRY MATTHEW D

CIK 00014543373 companiesSAN FRANCISCO, CA
SEC Profile

Transactions

30

Companies

3

Filings

14

CIK

0001454337

Recent Transactions

30 trades
  • Award
    XOMA Royalty Corp$XOMA

    Common Stock

    2025-05-21+5,971→ 23,840 total
  • Award
    XOMA Royalty Corp$XOMA

    Common Stock

    2024-05-15+6,070→ 17,869 total
  • Disposition to Issuer
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2023-06-26−80,000→ 0 total
  • Disposition to Issuer
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2023-06-26−120,000→ 0 total
  • Disposition to Issuer
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2023-06-26−80,000→ 0 total
  • Disposition to Issuer
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2023-06-26−50,000→ 0 total
  • Disposition to Issuer
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2023-06-26−80,000→ 0 total
  • Disposition from Tender
    CTI BIOPHARMA CORP

    Common Stock

    2023-06-26$9.10/sh−43,139→ 0 total
  • Disposition to Issuer
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2023-06-26−60,000→ 0 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Share Option (right to buy)

    2023-05-17+10,967→ 10,967 total
  • Award
    CTI BIOPHARMA CORP

    Stock Option (right to buy)

    2023-04-05+80,000→ 80,000 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Share Option (right to buy)

    2022-05-18+8,996→ 8,996 total
  • Award
    CTI BIOPHARMA CORP

    Stock Option (right to buy)

    2022-03-09+80,000→ 80,000 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Stock Option (right to buy)

    2021-05-19+5,101→ 5,101 total
  • Award
    CTI BIOPHARMA CORP

    Stock Option (right to buy)

    2021-03-10+80,000→ 80,000 total
  • Purchase
    XOMA Royalty Corp$XOMA

    8.625% Series A Cumulative Perpetual Preferred Stock

    2020-12-11$25.00/sh+200,000→ 200,000 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Stock Option (right to buy)

    2020-05-20+6,152→ 6,152 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Stock Option (right to buy)

    2019-05-16+8,167→ 8,167 total
  • Award
    CTI BIOPHARMA CORP

    Non-Qualified Stock Option (Right to Buy)

    2019-05-16+120,000→ 120,000 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Stock Option (right to buy)

    2018-05-17+5,052→ 5,052 total
  • Award
    CTI BIOPHARMA CORP

    Non-Qualified Stock Option (Right to Buy)

    2018-05-17+60,000→ 60,000 total
  • Exercise/Conversion
    CTI BIOPHARMA CORP

    Restricted Stock Units

    2017-04-28−34,736→ 0 total
  • Exercise/Conversion
    CTI BIOPHARMA CORP

    Common Stock

    2017-04-28+34,736→ 43,139 total
  • Award
    XOMA Royalty Corp$XOMA

    Non-Qualified Stock Option (right to buy)

    2017-03-02+15,222→ 15,222 total
  • Award
    XOMA Royalty Corp$XOMA

    Common Stock, $0.0075 par value per share

    2017-03-02+11,799→ 11,799 total
  • Award
    CTI BIOPHARMA CORP

    Stock Option (Right to Buy)

    2017-02-23+50,000→ 50,000 total
  • Exercise/Conversion
    CTI BIOPHARMA CORP

    Common Stock

    2017-01-11+8,403→ 8,403 total
  • Exercise/Conversion
    CTI BIOPHARMA CORP

    Restricted Stock Units

    2017-01-11−8,403→ 0 total
  • Award
    CTI BIOPHARMA CORP

    Restricted Stock Units

    2016-04-29+347,360→ 431,394 total
  • Award
    CTI BIOPHARMA CORP

    Restricted Stock Units

    2016-01-11+84,034→ 84,034 total

Companies

3

Recent Filings

14

Address

ONE SANSOME STREET 31ST FLOOR

SAN FRANCISCO, CA, 94104

View on SEC.gov